## Bone Marrow Iron Stores: The Discriminator ### Pathophysiologic Basis **Key Point:** Iron stores in bone marrow macrophages (assessed by Prussian blue staining) are the single best morphologic discriminator between IDA and anemia of chronic disease (ACD). IDA shows absent/depleted stores; ACD shows normal or increased stores with impaired utilization. ### Bone Marrow Findings Comparison Table | Finding | Iron Deficiency Anemia | Anemia of Chronic Disease | | --- | --- | --- | | **Iron Stores (Prussian Blue)** | Absent or markedly reduced | Normal or increased | | **Sideroblasts** | Absent or rare | Reduced (impaired utilization) | | **Marrow Cellularity** | Hypercellular (erythroid hyperplasia) | Normocellular or hypocellular | | **Erythroid Precursors** | Increased (response to anemia) | Normal or decreased | | **Hemosiderin in Macrophages** | None | Present | | **Pathophysiology** | Depleted iron stores | Iron sequestered; hepcidin ↑ | ### Why Prussian Blue Stain is Diagnostic **High-Yield:** Prussian blue staining detects hemosiderin (storage iron) in bone marrow macrophages: - **IDA:** No blue granules = absent iron stores (the hallmark of iron deficiency) - **ACD:** Blue granules present = normal/increased iron stores, but hepcidin-mediated block prevents iron utilization **Clinical Pearl:** This distinction is critical because IDA requires iron supplementation, while ACD does not. Giving iron to an ACD patient is futile and may cause harm (iron overload). ### Why Other Options Are Shared Features Hypercellular marrow with erythroid hyperplasia, microcytic hypochromic normoblasts, and reduced sideroblasts can occur in both conditions as responses to anemia or iron unavailability. Only the **absence of iron stores** is pathognomonic for IDA. [cite:Robbins 10e Ch 14]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.